Biosimilar medicine authorized by the AEMPS
ACTIVE PRINCIPLE: Somatropin
DATE: 06/07/2006
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.
PRIVACY POLICY
SUBSCRIBE
